I simply think recent price action in the face of all this good news and prospects is telling us something .... even in the unfriendly OTC environment. I am invested because I believe in in this company, Joe's strategy and his process of implementation. I certainly do not think they are fabricating any results. To me the stock and todays call is telling me that all will take a bit longer to come together. I feel confident the 10K will be satisfactory in all respects although nothing will be in it to move PPS. PPS is telling me that unless we have some FDA approvals or higher than expected revenues/profits or real tangible success from one of our acquisitions very .... PPS may well dip under $2 and we will all have to get used to a more drawn out timeline. I truly hope I'm wrong and you can take me to task.
............
not sure how you arrive at these dismal conclusions, but I think you are way off base. We only need to document shareholder equity and assets under management before uplisting is approved. We don't need any "surprises" in the 10k. Approval has nothing to do with more success out of any "assets" as you say. What surprises are you thinking the 10k will have that we need? We don't need surprises, we just need audited documentation of what has already been in the quarterly reports. And since I do not believe the company has been fabricating the quarterly reports, I am just waiting for the 10k for Nasdaq's purposes. And that should be any day - not months from now. How do you arive at your "50/50" chance of uplisting before Xmas? Did you just pull that out of a hat?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links